Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Icos Corp.

(ICOS), Bothell, Wash.

Business: Autoimmune/Inflammation

Robertson, Stephens analyst Edward Hurwitz

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE